» Articles » PMID: 23241100

Multiple Myeloma and Lifetime Occupation: Results from the EPILYMPH Study

Abstract

Unlabelled:

Background: The EPILYMPH study applied a detailed occupational exposure assessment approach to a large multi-centre case-control study conducted in six European countries. This paper analysed multiple myeloma (MM) risk associated with level of education, and lifetime occupational history and occupational exposures, based on the EPILYMPH data set.

Methods: 277 MM cases and four matched controls per each case were included. Controls were randomly selected, matching for age (+/- 5 years), centre and gender. Lifetime occupations and lifetime exposure to specific workplace agents was obtained through a detailed questionnaire. Local industrial hygienists assessed likelihood and intensity for specific exposures. The odds ratio and 95% confidence intervals (OR, 95% CI) were calculated for level of education, individual occupations and specific exposures. Unconditional logistic regression models were run for individual occupations and exposures.

Results: A low level of education was associated with MM OR=1.68 (95% CI 1.02-2.76). An increased risk was observed for general farmers (OR=1.77; 95% CI 1.05-2.99) and cleaning workers (OR=1.69; 95% CI 1.04-2.72) adjusting for level of education. Risk was also elevated, although not significant, for printers (OR=2.06; 95% CI 0.97-4.34). Pesticide exposure over a period of ten years or more increased MM risk (OR=1.62; 95% CI 1.01-2.58).

Conclusion: These results confirm an association of MM with farm work, and indicate its association with printing and cleaning. While prolonged exposure to pesticides seems to be a risk factor for MM, an excess risk associated with exposure to organic solvents could not be confirmed.

Citing Articles

Multiple Myeloma and Occupational Risk Factors: A Narrative Review.

Hejrati A, Parvin S, Omidali M, Hejrati L, Amiri B Iran J Public Health. 2024; 53(3):568-576.

PMID: 38919290 PMC: 11194647. DOI: 10.18502/ijph.v53i3.15137.


Real world evidence of epidemiological trends, clinical presentation, and prognostic outcomes of multiple myeloma (2007-2021).

Elsabah H, El Omri H, Habas E, Y Taha R, A ElKourashy S, Ibrahim F Front Med (Lausanne). 2024; 11:1338552.

PMID: 38444413 PMC: 10912627. DOI: 10.3389/fmed.2024.1338552.


It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma.

Choa R, Panaroni C, Bhatia R, Raje N Blood Adv. 2023; 7(18):5510-5523.

PMID: 37493975 PMC: 10515310. DOI: 10.1182/bloodadvances.2023010822.


Evaluation of hematological indices among insecticides factory workers.

Nejatifar F, Abdollahi M, Attarchi M, Atrkar Roushan Z, Etemadi Deilami A, Joshan M Heliyon. 2022; 8(3):e09040.

PMID: 35299610 PMC: 8920855. DOI: 10.1016/j.heliyon.2022.e09040.


Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study.

Lin W, Tsai F Biomed Hub. 2022; 6(3):138-144.

PMID: 35083226 PMC: 8740171. DOI: 10.1159/000519704.


References
1.
Dosemeci M, Blair A . Occupational cancer mortality among women employed in the telephone industry. J Occup Med. 1994; 36(11):1204-9. DOI: 10.1097/00043764-199411000-00006. View

2.
Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View

3.
Khuder S, Mutgi A . Meta-analyses of multiple myeloma and farming. Am J Ind Med. 1997; 32(5):510-6. DOI: 10.1002/(sici)1097-0274(199711)32:5<510::aid-ajim11>3.0.co;2-5. View

4.
Larsson S, Wolk A . Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer. 2007; 121(11):2512-6. DOI: 10.1002/ijc.22968. View

5.
t Mannetje A, Dryson E, Walls C, Mclean D, McKenzie F, Maule M . High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study. Occup Environ Med. 2007; 65(5):354-63. DOI: 10.1136/oem.2007.035014. View